Navigation Links
Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry

Basel (Switzerland) and Tokyo (Japan) (PRWEB) February 07, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Ono Pharmaceutical Co., Ltd.. (Ono) extended its Genedata collaboration with a license of Genedata Expressionist for Mass Spectrometry. Ono is a leading R&D-oriented international pharmaceutical company, which provides treatments for oncological and cardiovascular diseases. The Genedata Expressionist system, an enterprise and comprehensive platform for omics data management, will be used by Ono to further strengthen its targeted proteomics and metabolomics research.

“Our daily research demands accurate mass profiling analysis as well as powerful MRM capabilities for effective quantitative analysis,” noted a spokesperson for the Tsukuba Research Institute at Ono. “Genedata Expressionist for Mass Spectrometry supports our proteomics and metabolomics research with a sophisticated data analysis platform that can process chromatograms ranging from 2MB to over 1GB. And, the system’s ability to integrate data from a variety of instruments is a valuable benefit to us. Finally, with Genedata Expressionist we can rely on superior algorithms that generate clinically relevant biomarkers supporting efficient research processes.”

Experimental designs of molecular profiling studies in the life sciences are continually growing in complexity and size. Genedata Expressionist analyzes and manages genomic, transcriptomics, proteomics, metabolomics, and epigenomics data from leading technologies including next-generation sequencing, high-density microarrays, RT-PCR, and other genomic tools. Additionally, Genedata Expressionist enables integrated analysis and management of all major mass spectrometry (MS) profiling applications including a comprehensive solution for proteomic, metabolomics, and lipidomics data from all major MS technologies. With robust support of MRM data, the system’s innovative capabilities include:

  •     Data Visualization
  •     Background Subtraction
  •     Grid Alignment
  •     Peak Detection
  •     Annotation

“We are proud of our collaboration with Ono, one of the world’s leading pharmaceutical companies providing innovative drug therapies,” said Dr. Othmar Pfannes, CEO of Genedata. “With Genedata Expressionist and its support of innovative technologies such as MS and next-generation sequencing, we provide an integrative computational platform that supports customers such as Ono who are pioneering novel therapies. And, we are committed to continuous innovation by expanding the scope Genedata Expressionist applications in areas such as molecular diagnostics and personalized healthcare.”

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US.

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Packaging Machinery Manufacturer, Sepha Ltd.Reports Record Year for Sales of its Visionscan Leak Detection Machine and its Pharmaceutical Deblistering Equipment
2. DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies
3. Oramed Pharmaceuticals Announces Reverse Stock Split
4. Todays Research on Mylan and Watson Pharmaceuticals: One Drug Makers Sorrow is Another Ones Joy
5. Biscayne Pharmaceuticals Closes $1.5 Million Financing To Advance Recent Discoveries Of Pioneering Endocrine Drug Researcher
6. Eckert & Ziegler Vitalea Science and Korea-based BioCore Bring Human Microdosing to Korea to Address the Needs of the Emergent Pharmaceutical Industry
7. UPM Pharmaceuticals Enhances its Pre-Formulation Capabilities
8. Biosim Pharmaceuticals, Manufacturers of Generic ACTHAR, to Participate at Biotech Showcase 2013
9. Asia-Pacific Active Pharmaceutical Ingredients (APIs) Market Analysis & Forecasts to 2017 in New Research Report @
10. Rafarma Pharmaceuticals, Inc. Achieves Full Certification
11. K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization
Post Your Comments:
(Date:10/13/2015)... , October 13, 2015 " ... and Forecast 2015 - 2023 " , the ... and is anticipated to reach US$7.59 bn by 2023, expanding at ... 2023. --> " Microbiology Culture Market - Global ... " , the global microbiology culture market was ...
(Date:10/13/2015)... --      Q BioMed Inc (OTC: QBIO), ... a strategic relationship with Wombat Capital, Ltd., a ... France based strategic and scientific advisory firm.. ... collaborative arrangement gives Q BioMed and its stakeholders access ... as long established pharmaceutical industry relationships. The advisors within ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... and distributor of automation systems, material handling solutions and components, is opening its ... I-94 near State Street, the facility is Exotic’s second major expansion in Metropolitan ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... educational opportunities for school age children in the areas of Science, Technology, Engineering ... sectors of the national economy, and the program aims to increase the number ...
Breaking Biology Technology:
(Date:10/6/2015)... 2015  Maverix Biomics, Inc., a leading genomic ... software portfolio with the debut of its RNA-Seq ... in eukaryotes. The software is integrated into the ... analysis solution that leverages proven open-source algorithms and ... efforts. Garry Nolan,s laboratory at ...
(Date:9/30/2015)... , Sept. 30, 2015  The U.S. Court of ... another key ruling in favor of Crossmatch ™, ... fingerprint scanner company Suprema and its U.S. partner Mentalix ... a trade provision that declares it unlawful to engage ... infringing two of Crossmatch,s patents, the 5,900,993 patent and ...
(Date:9/28/2015)...  The monitoring of vital signs, such as ... an essential component of patient assessment. Changes in ... a patient,s condition. However, in general care areas ... during routine observation rounds only once every four ... these observation rounds, the warning signs can go ...
Breaking Biology News(10 mins):